HLS Therapeutics Inc (TSE:HLS)

HLS Therapeutics Inc (HLS) Financial Statements


HLS Therapeutics Inc Financial Overview

HLS Therapeutics Inc's market cap is currently ―. The company's EPS TTM is C$-1.166; its P/E ratio is -3.09; HLS Therapeutics Inc is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is C$-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 12.47M$ 15.86M$ 16.04M$ 16.42M$ 14.76M
Gross Profit$ 10.70M$ 13.33M$ 14.17M$ 14.64M$ 13.31M
EBIT$ -3.51M$ -2.51M$ -5.23M$ -7.39M$ -3.92M
EBITDA$ 2.41M$ 4.53M$ 2.98M$ 976.00K$ 4.40M
Net Income Common Stockholders$ -6.11M$ -5.40M$ -6.90M$ -9.44M$ -5.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.44M$ 21.95M$ 21.81M$ 20.93M$ 21.21M
Total Assets$ 197.75M$ 209.06M$ 215.23M$ 226.82M$ 234.16M
Total Debt$ 6.88M$ 6.88M$ 7.10M$ 13.01M$ 95.20M
Net Debt$ -12.56M$ -15.08M$ -14.71M$ -7.92M$ 73.98M
Total Liabilities$ 108.69M$ 111.36M$ 113.43M$ 115.38M$ 115.26M
Stockholders Equity$ 89.07M$ 97.70M$ 101.80M$ 111.44M$ 118.89M
Cash Flow-
Free Cash Flow$ 776.00K$ 3.72M$ 5.33M$ 2.53M$ 4.02M
Operating Cash Flow$ 778.00K$ 3.73M$ 5.37M$ 2.67M$ 4.02M
Investing Cash Flow$ -2.00K$ -14.00K$ -40.00K$ -135.00K-
Financing Cash Flow$ -3.03M$ -3.89M$ -4.29M$ -2.95M$ -3.51M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

HLS Therapeutics Inc Debt to Assets

HLS Therapeutics Inc Cash Flow

HLS Therapeutics Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis